226 related articles for article (PubMed ID: 35488518)
1. Apparent Diffusion Coefficient MRI Shows Association With Early Progression of Unresectable Intrahepatic Cholangiocarcinoma With Combined Targeted-Immunotherapy.
Sheng R; Sun W; Huang X; Jin K; Gao S; Zeng M; Wu D; Shi G
J Magn Reson Imaging; 2023 Jan; 57(1):275-284. PubMed ID: 35488518
[TBL] [Abstract][Full Text] [Related]
2. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
[TBL] [Abstract][Full Text] [Related]
3. Unresectable Intrahepatic Cholangiocarcinoma: Multiparametric MR Imaging to Predict Patient Survival.
Pandey A; Pandey P; Aliyari Ghasabeh M; Najmi Varzaneh F; Shao N; Khoshpouri P; Zarghampour M; Fouladi DF; Liddell R; Kamel IR
Radiology; 2018 Jul; 288(1):109-117. PubMed ID: 29584595
[TBL] [Abstract][Full Text] [Related]
4. Baseline Volumetric Multiparametric MRI: Can It Be Used to Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma Undergoing Transcatheter Arterial Chemoembolization?
Pandey A; Pandey P; Ghasabeh MA; Zarghampour M; Khoshpouri P; Ameli S; Luo Y; Kamel IR
Radiology; 2018 Dec; 289(3):843-853. PubMed ID: 30129899
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced MRI could predict response of systemic therapy in advanced intrahepatic cholangiocarcinoma.
Sheng R; Huang X; Jin K; Gao S; Zeng M; Wu D; Shi G
Eur Radiol; 2022 Aug; 32(8):5156-5165. PubMed ID: 35298678
[TBL] [Abstract][Full Text] [Related]
6. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
[TBL] [Abstract][Full Text] [Related]
7. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
[TBL] [Abstract][Full Text] [Related]
8. MRI for Hepatitis B-Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study.
Sheng R; Wang H; Zhang Y; Sun W; Jin K; Dai Y; Zhang W; Zeng M; Zhou J
J Magn Reson Imaging; 2024 Mar; 59(3):1093-1104. PubMed ID: 37309823
[TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient value of mass-forming intrahepatic cholangiocarcinoma: a potential imaging biomarker for prediction of lymph node metastasis.
Zhou Y; Zhou G; Gao X; Xu C; Wang X; Xu P
Abdom Radiol (NY); 2020 Oct; 45(10):3109-3118. PubMed ID: 32107582
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.
Lewis S; Besa C; Wagner M; Jhaveri K; Kihira S; Zhu H; Sadoughi N; Fischer S; Srivastava A; Yee E; Mortele K; Babb J; Thung S; Taouli B
Eur Radiol; 2018 May; 28(5):2047-2057. PubMed ID: 29234913
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging.
Fattach HE; Dohan A; Guerrache Y; Dautry R; Boudiaf M; Hoeffel C; Soyer P
Eur J Radiol; 2015 Aug; 84(8):1444-1451. PubMed ID: 26022518
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
13. Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma.
Yamada S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Saito Y; Yoshikawa M; Miyazaki K; Shimada M
J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):388-395. PubMed ID: 32162483
[TBL] [Abstract][Full Text] [Related]
14. LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.
Hwang JA; Lee S; Lee JE; Yoon J; Choi SY; Shin J
J Magn Reson Imaging; 2023 Mar; 57(3):930-938. PubMed ID: 35833798
[TBL] [Abstract][Full Text] [Related]
15. Value of diffusion-weighted MR imaging in the diagnosis of lymph node metastases in patients with cholangiocarcinoma.
Holzapfel K; Gaa J; Schubert EC; Eiber M; Kleeff J; Rummeny EJ; Loos M
Abdom Radiol (NY); 2016 Oct; 41(10):1937-41. PubMed ID: 27271285
[TBL] [Abstract][Full Text] [Related]
16. Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features.
King MJ; Hectors S; Lee KM; Omidele O; Babb JS; Schwartz M; Tabrizian P; Taouli B; Lewis S
Cancer Imaging; 2020 Jul; 20(1):43. PubMed ID: 32620153
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?
Kovač JD; Galun D; Đurić-Stefanović A; Lilić G; Vasin D; Lazić L; Mašulović D; Šaranović Đ
Acta Radiol; 2017 Dec; 58(12):1417-1426. PubMed ID: 28350257
[TBL] [Abstract][Full Text] [Related]
18. A Multiparametric Fusion Deep Learning Model Based on DCE-MRI for Preoperative Prediction of Microvascular Invasion in Intrahepatic Cholangiocarcinoma.
Gao W; Wang W; Song D; Wang K; Lian D; Yang C; Zhu K; Zheng J; Zeng M; Rao SX; Wang M
J Magn Reson Imaging; 2022 Oct; 56(4):1029-1039. PubMed ID: 35191550
[TBL] [Abstract][Full Text] [Related]
19. Prediction of recurrence in solid nonfunctioning pituitary macroadenomas: additional benefits of diffusion-weighted MR imaging.
Ko CC; Chen TY; Lim SW; Kuo YT; Wu TC; Chen JH
J Neurosurg; 2019 Feb; 132(2):351-359. PubMed ID: 30717054
[TBL] [Abstract][Full Text] [Related]
20. Value of Intravoxel Incoherent Motion (IVIM) Imaging for Differentiation between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Wang J; Yang Z; Luo M; Xu C; Du M; Liu Y
Contrast Media Mol Imaging; 2022; 2022():1504463. PubMed ID: 35615729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
